[HAPSENG] YoY Cumulative Quarter Result on 30-Jun-2011 [#2]

Stock
[HAPSENG] HAP SENG CONSOLIDATED BHD
Announcement Date
24-Aug-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Jun-2011 [#2]
Profit Trend
QoQ- 110.17%
YoY- 0.32%
Quarter Report
Latest QR
Upcoming QR
HAPSENG's Result
HAPSENG's Financial Summary
View:
Show?
Cumulative Result
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Revenue 1,955,857 1,619,226 1,813,027 1,709,868 1,251,697 1,138,609 1,339,883 6.50%
PBT 551,218 393,957 297,698 316,117 243,443 86,178 312,908 9.89%
Tax -146,588 -76,655 -74,673 -81,074 -34,437 -14,032 -78,063 11.06%
NP 404,630 317,302 223,025 235,043 209,006 72,146 234,845 9.48%
-
NP to SH 370,620 304,333 189,038 172,707 172,156 53,980 207,814 10.11%
-
Tax Rate 26.59% 19.46% 25.08% 25.65% 14.15% 16.28% 24.95% -
Total Cost 1,551,227 1,301,924 1,590,002 1,474,825 1,042,691 1,066,463 1,105,038 5.81%
-
Net Worth 3,445,764 3,418,764 3,371,794 8,699,999 2,468,226 2,327,112 2,203,234 7.73%
Dividend
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Div 200,335 167,792 97,890 72,038 33,811 28,173 28,174 38.65%
Div Payout % 54.05% 55.13% 51.78% 41.71% 19.64% 52.19% 13.56% -
Equity
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Net Worth 3,445,764 3,418,764 3,371,794 8,699,999 2,468,226 2,327,112 2,203,234 7.73%
NOSH 2,003,351 2,097,401 2,175,351 1,847,133 563,522 563,465 563,486 23.52%
Ratio Analysis
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
NP Margin 20.69% 19.60% 12.30% 13.75% 16.70% 6.34% 17.53% -
ROE 10.76% 8.90% 5.61% 1.99% 6.97% 2.32% 9.43% -
Per Share
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
RPS 97.63 77.20 83.34 92.57 222.12 202.07 237.78 -13.78%
EPS 18.50 14.51 8.69 9.35 30.55 9.58 36.88 -10.85%
DPS 10.00 8.00 4.50 3.90 6.00 5.00 5.00 12.24%
NAPS 1.72 1.63 1.55 4.71 4.38 4.13 3.91 -12.78%
Adjusted Per Share Value based on latest NOSH - 1,878,277
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
RPS 78.56 65.04 72.82 68.68 50.28 45.73 53.82 6.50%
EPS 14.89 12.22 7.59 6.94 6.91 2.17 8.35 10.11%
DPS 8.05 6.74 3.93 2.89 1.36 1.13 1.13 38.69%
NAPS 1.384 1.3732 1.3543 3.4944 0.9914 0.9347 0.8849 7.73%
Price Multiplier on Financial Quarter End Date
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Date 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 -
Price 3.60 2.05 1.80 1.75 0.96 0.83 0.92 -
P/RPS 3.69 2.66 2.16 1.89 0.43 0.41 0.39 45.40%
P/EPS 19.46 14.13 20.71 18.72 3.14 8.66 2.49 40.84%
EY 5.14 7.08 4.83 5.34 31.82 11.54 40.09 -28.97%
DY 2.78 3.90 2.50 2.23 6.25 6.02 5.43 -10.55%
P/NAPS 2.09 1.26 1.16 0.37 0.22 0.20 0.24 43.41%
Price Multiplier on Announcement Date
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Date 27/08/14 19/08/13 30/08/12 24/08/11 25/08/10 26/08/09 26/08/08 -
Price 3.73 2.11 1.64 1.30 0.88 0.85 0.80 -
P/RPS 3.82 2.73 1.97 1.40 0.40 0.42 0.34 49.62%
P/EPS 20.16 14.54 18.87 13.90 2.88 8.87 2.17 44.96%
EY 4.96 6.88 5.30 7.19 34.72 11.27 46.10 -31.02%
DY 2.68 3.79 2.74 3.00 6.82 5.88 6.25 -13.15%
P/NAPS 2.17 1.29 1.06 0.28 0.20 0.21 0.20 48.76%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment